cetylpyridinium chloride anhydrous has been researched along with Leukopenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruserud, Ø; Ersvaer, E; Gjertsen, BT; Liseth, K; Skavland, J | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Leukopenia
Article | Year |
---|---|
Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells.
Topics: Adult; Antineoplastic Agents; CD3 Complex; CD8-Positive T-Lymphocytes; Cell Movement; Female; Forkhead Transcription Factors; Health; Humans; Interleukin-2 Receptor alpha Subunit; Leukemia, Myeloid, Acute; Leukopenia; Male; Middle Aged; Sex Characteristics; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Tumor Cells, Cultured; Young Adult | 2010 |